Discontinuation report RANITIDINE
Report ID | 120746 |
Drug Identification Number | 00740756 |
Brand name | RANITIDINE |
Common or Proper name | RANITIDINE -300 |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | Regulatory issues- Enjeux réglementaires We are looking to re-introduce into the market |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-04-01 | French | Compare |
v5 | 2021-04-01 | English | Compare |
v4 | 2020-07-22 | French | Compare |
v3 | 2020-07-22 | English | Compare |
v2 | 2020-07-22 | French | Compare |
v1 | 2020-07-22 | English | Compare |
Showing 1 to 6 of 6